COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Asthma and Intimate Partner Violence

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04216680
Recruitment Status : Recruiting
First Posted : January 3, 2020
Last Update Posted : January 6, 2020
Information provided by (Responsible Party):
Eileen Wang, National Jewish Health

Brief Summary:
This is a cross-sectional observational study on adult asthmatics evaluating the relationship between asthma control and psychosocial factors to include intimate partner violence, stress, anxiety, depression, post-traumatic stress disorder.

Condition or disease
Asthma Domestic Violence

Layout table for study information
Study Type : Observational
Estimated Enrollment : 60 participants
Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Asthma and Intimate Partner Violence
Estimated Study Start Date : January 2, 2020
Estimated Primary Completion Date : January 2, 2021
Estimated Study Completion Date : January 2, 2021

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Asthma

Primary Outcome Measures :
  1. Asthma Control Test [ Time Frame: last 30 days ]
    asthma control scored on scale of 0-25 with higher numbers reflecting better control.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 69 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Adult asthmatics ages 18-69 years who are able to participate in a questionnaire-based study.

Inclusion Criteria:

  • Diagnosis of asthma as defined as postbronchodilator response of at least 12% and 200 milliliters improvement in forced expiratory volume in 1 second (FEV1) or forced vital capacity and/or evidence of positive airway hyperresponsiveness.

Exclusion Criteria:

  • Medical factors that would preclude participation as determined by the investigators. Examples include blindness, mental illness that grossly impairs judgment, or active injury requiring treatment.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT04216680

Layout table for location contacts
Contact: Eileen Wang, MD, MPH 303-270-2796 WANGE@NJHEALTH.ORG

Layout table for location information
United States, Colorado
National Jewish Health Recruiting
Denver, Colorado, United States, 80206
Contact: Eileen Wang    303-270-2796   
Sponsors and Collaborators
National Jewish Health
Layout table for additonal information
Responsible Party: Eileen Wang, Assistant Professor, National Jewish Health Identifier: NCT04216680    
Other Study ID Numbers: HS-3068
First Posted: January 3, 2020    Key Record Dates
Last Update Posted: January 6, 2020
Last Verified: January 2020

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases